| Ytd | 750.96% | |
| 1y | 789.48% |
| Open | 5.96 | Prev Close | 5.95 | Low | 5.87 | High | 6.68 | Mkt Cap | 12.05M |
| Vol | 43.38K | Avg Vol | 55.52K | EPS | -161.13 | P/E | N/A | Forward P/E | -0.26 |
| Beta | 0.57 | Short Ratio | 0.71 | Inst. Own | 67.52% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 7.21 | 200-d Avg | 10.80 | 1yr Est | 11.00 |
Gainers PDS Biotechnology (NASDAQ:PDSB) shares rose 63.7% to $0.65 during Tuesday's regular ses
FDA clearance of a new IND for GTB-5550 in multiple myeloma (MM) under an investigator sponsored tri
FDA clearance of a new IND for GTB-5550 in multiple myeloma (MM) under an investigator sponsored tri
GT Biopharma secures FDA IND clearance for GTB-5550, advancing its TriKE therapy into Phase 1 clinic
Gainers Basel Medical Group (NASDAQ:BMGL) shares moved upwards by 59.8% to $7.32 during Monday'
Gainers Biodexa Pharmaceuticals (NASDAQ:BDRX) shares increased by 110.6% to $1.39 during Friday'